Case reportPostural tachycardia syndrome: Reversal of sympathetic hyperresponsiveness and clinical improvement during sodium loading☆
References (6)
- et al.
Hyperbradykinnism: A new orthostatic syndrome
Lancet
(1972) Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system
New Engl J Med
(1980)- et al.
Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to upright posture
J Clin Endocrinol Metab
(1974)
Cited by (103)
Orthostatic Intolerance and Chiari I Malformation
2023, Neurosurgery Clinics of North AmericaDizziness, Syncope, and Autonomic Dysfunction in Children
2022, Progress in Pediatric CardiologyCardiovascular exercise as a treatment of postural orthostatic tachycardia syndrome: A pragmatic treatment trial
2021, Heart RhythmCitation Excerpt :The chronic nature of the disease and the severity of symptoms result in diminished quality of life across multiple domains.3,4 A number of pharmacological treatment options for POTS exist including β-blockade, blood volume expansion, and induced hypertension, but there are no studies of pharmacotherapeutic interventions above level B evidence.5–11 Furthermore, the off-label use of many medications has not afforded the majority of patients with POTS a successful outcome.12–14
Improved Acute Orthostatic Tolerance in POTS by Lower Body Compression: Both Beneficial and Sufficient?
2021, Journal of the American College of CardiologyClinical neurophysiology of postural tachycardia syndrome
2019, Handbook of Clinical NeurologyCitation Excerpt :The typical age of presentation is between 15 and 50 years (Schondorf and Low, 1993; Thieben et al., 2007). Early studies suggested men and women were affected equally (Fouad et al., 1986; Hoeldtke et al., 1989), but the preponderance of more recent work has shown an overrepresentation of women (Rosen and Cryer, 1982; Schondorf and Low, 1993; Low et al., 1994; Thieben et al., 2007) at a ratio of approximately 5:1. Symptoms of cerebral hypoperfusion that may occur with any of the OI disorders include lightheadedness, dizziness, presyncope, blurred vision, generalized weakness, and cognitive difficulties.
Postural tachycardia syndrome (PoTS): An up-to-date
2018, Revue de Medecine Interne
- ☆
This study was supported in part by U.S. Public Health grants AM 27085, RR00036 and AM 20579.
- 1
From the Metabolism Division of the Department of Medicine, Washington University School of Medicine, 660 South Euclid, St. Louis, Missouri 63110.